On the basis of the data sets from cBioportal18, 26, Parkin mutations are observed in < 1% of breast cancer, suggesting that mutation is not a major mechanism contributing to the frequent downregulation of Parkin in breast cancer (Supplementary Fig. 1c). This evidence concerns the gene PRKN and breast cancer.